Investment Q&A

Q: In an answer today you stated '20% of biotech companies in the US now trading below cash levels'. What would be your top biotech picks and/or your top biotech ETFs to play a recovery?

Q: Could you provide comments on earnings and future prospects for this company. Is this company hold, sell or buy more?
Thank you

Q: Related to Kevin's question... I own U, CRWD and NVDA in a TFSA and can't capture a tax loss if I were to sell U (I'm down significantly on the position). Would you suggest continuing to hold U in a registered account or selling and moving on to something else (likely increase NVDA holdings)?

Q: Greetings 5i team and thank you for answering the phone during these rocky times.
The 30 Apr 22 Model Inc Portfolio has LNF at a 'B' whereas the 3 Sep 21 Report on LNF is 'B+'. Plse confirm LNF is a 'B+'. Also, if you were to write a report on LNF today would you be likely to maintain the 'B+'?
Thanks again
SP

Q: Is there any small cap companies that have caught your interest for insider buying.

Q: For your "Portfolio $ total yield" in summary statistics, I assume that it includes both the dollar amount of dividends and income that the portfolio throws off?

Q: Hi,

Your comments on Converge latest results ? Is it still a buy ?

Thanks

Q: Hello Peter,

For a mid-risk investor who just retired and has a little cash to work with in a registered account what is your perspective on:

Opening a 1/2 position of VGT or just add 1/4 position to MFST or Appl to a full position.?

Which stock(s) would you be ok with today to be 6%-8% of a portfolio for a 5-10 year hold? Please rank the stocks if there is more than one possible choice.

Thank you
Debbie and Jerry

Q: Hi Peter, Ryan, and Team,

In reading answers to questions posed by others, I get the impression that 5i isn't in favour of averaging down as an investment strategy, due to the potential for further losses. These possible losses are of course greater for individual stocks and less so for ETFs, according to what I've read.

However, if a non-registered account contains some cash, and the holdings are ones that 5i has made positive comments in the past, in what order might you consider adding to the following?
HXS (down 8.86%)
SJ (down 18.7%)
TCN (down 12.62%)

Thanks for your guidance and respected advice.

Q: Hello Peter and team,
What do you think of Cohen and Steers and Icahn Enterprises. i am just concerned of the high yield . Is this sustainable? I am looking at these for my RRSP where the dividends don't have tax implications until i withdraw funds.

Q: DND seems to be getting hit hard again. Do you think this is people selling before the earnings later this month in combination with market backdrop? I think this company has been overly beat up. Even if their purchase in Australia is not allowed they are still growing at a good pace are they not?. Would you add to a position today to lower cost? I am down about 25% money not needed for 10+ years. Thanks

Q: Morning do you think there is something fishy going on with the recent downturn after what appeared to be stellar result?

Q: Hello 5I,
I am down 50% on the above stocks. They are in taxable accounts but it’s not completely necessary for me to take losses necessary. I want to stay invested but am I just better to stay in these names or switch to something else? Basically are these good names to just stay in when things turn positive or do you highly recommend other names?
Thanks

Q: Thoughts on these quarterly results? Do you still like the long term prospects of these three growth companies?

In general, what are your thoughts on holding growthier names in this current market? It just seems that the risk of holding these positions through earnings outweighs the benefits. For example, if a company meets expectations and maintains guidance, the stock barely moves. However, any miss or lower guidance and the stock easily gets crushed 30-50%, such as NFLX, FB, UPST, RBLX, COIN, etc... Seems a lot of companies are issuing lower guidance because of all the uncertainties. Wouldn't it be better or more prudent to just sell or maybe trim the positions to reflect these risks and re-enter later?

Other growth names I have on deck soon are GSY, WELL, AT, EGLX, LSPD, NVDA, APPS, and CRWD and I'm worried about how investors will react to earnings. Thanks!

Q: Could you please clarify your recent response to Greg on Unity. When you say
"A better market would see this stock rise sharply, but we would be more inclined to be on the sidelines after this report. It was just not good. "
Is this a suggestion to sell an existing position ( registered or non-registered account) ? Or, are you merely suggesting not to buy or add to an existing position at this point ?
Thank you.

Q: Thanks for the Unity answer. How does the weakness in ads for gaming, mobility issues read through to companies like Eglx, at? Won’t they have similar headwinds? Regards greg

Q: I'm a new subscriber to your services this year and much appreciate your independent thought on investments. What is a good fully diversified ETF that is capital gains oriented over dividends? I've focused on dividend paying stocks over past 30 years, and while I'm enjoying working - want to avoid paying more than 1/2 my dividends income to gov. When I stop working I would convert back to dividend based investments to provide my income. Thank you.

Q: TTD has taken a major drop in recent weeks and months. More so than many other stocks . Please give me your thoughts. Is this one to sell and take a loss for tax purposes and re-buy in 30 days ? Thanks.

Q: Follow-up question: : "The company noted it has reached its 40% renewables target." Does this include it's 60% ownership in Transalta renewable or is it in addition to.

Q: Crowdstrike has been in the category of "too expensive" for most of the past 10-12 months.
At what price range would you be a buyer of CRWD?
Ed